Literature DB >> 20535145

Testicular cancer: Decision tree model has potential to improve NSGCT management.

Ornob P Roy, Louis R Kavoussi.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20535145     DOI： 10.1038/nrurol.2010.62

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  10 in total

1.  High-risk clinical stage I NSGCT: the case for RPLND.

Authors:  Christopher Morash; Ilias Cagiannos
Journal:  World J Urol       Date:  2009-06-02       Impact factor: 4.226

2.  Short-term morbidity of primary retroperitoneal lymph node dissection in a contemporary group of patients.

Authors:  Stephen D W Beck; Matthew D Peterson; Richard Bihrle; John P Donohue; Richard S Foster
Journal:  J Urol       Date:  2007-06-11       Impact factor: 7.450

3.  Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcome.

Authors:  Andrew J Stephenson; George J Bosl; Robert J Motzer; Michael W Kattan; Jason Stasi; Dean F Bajorin; Joel Sheinfeld
Journal:  J Clin Oncol       Date:  2005-04-20       Impact factor: 44.544

Review 4.  Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.

Authors:  D Böhlen; M Borner; R W Sonntag; M F Fey; U E Studer
Journal:  J Urol       Date:  1999-04       Impact factor: 7.450

5.  Outcomes of surveillance protocol of clinical stage I nonseminomatous germ cell tumors-is shift to risk adapted policy justified?

Authors:  Rauf Taner Divrik; Bülent Akdoğan; Haluk Ozen; Ferruh Zorlu
Journal:  J Urol       Date:  2006-10       Impact factor: 7.450

6.  Estimating the risk of cancer associated with imaging related radiation during surveillance for stage I testicular cancer using computerized tomography.

Authors:  Tatum V Tarin; Geoffrey Sonn; Rajesh Shinghal
Journal:  J Urol       Date:  2008-12-16       Impact factor: 7.450

7.  Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party.

Authors:  G Read; S P Stenning; M H Cullen; M C Parkinson; A Horwich; S B Kaye; P A Cook
Journal:  J Clin Oncol       Date:  1992-11       Impact factor: 44.544

Review 8.  High-risk clinical stage I nonseminomatous germ cell tumors: the case for chemotherapy.

Authors:  Dirk H Westermann; Urs E Studer
Journal:  World J Urol       Date:  2009-07-28       Impact factor: 4.226

9.  Defining the optimal treatment for clinical stage I nonseminomatous germ cell testicular cancer using decision analysis.

Authors:  Carvell T Nguyen; Alex Z Fu; Timothy D Gilligan; Brian J Wells; Eric A Klein; Michael W Kattan; Andrew J Stephenson
Journal:  J Clin Oncol       Date:  2009-11-16       Impact factor: 44.544

10.  Morbidity of open retroperitoneal lymph node dissection for testicular cancer: contemporary perioperative data.

Authors:  Stephen B Williams; David W McDermott; Dock Winston; Eamonn Bahnson; Alexander M Berry; Graeme S Steele; Jerome P Richie
Journal:  BJU Int       Date:  2009-08-28       Impact factor: 5.588
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.